ReAlta Presents New Phase 2 Data in aGVHD
By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...

By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...
IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Andrew Keys,...
CorpGov and IPO Edge are pleased to provide complete video coverage of the fifth annual...
By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr....
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at...
By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive...
Download the Complete Report Here By Rayk Riechmann How to end a transformative year on...
Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com
By Karen Roman Vinson & Elkins said it advised Michael MacDougall, Founder and Managing Partner...
By Daniella Parra Sequana Medical said the first implantation of the alfapump in the U.S....